← Signal Board

Emergent BioSolutions financial statements

이머전트 바이오솔루션스NYSE:EBS · New York Stock Exchange · Healthcare · sector #17
$6.95-4.01%
2026-10-06 close

Emergent BioSolutions's published financial data is dated 2026-10-04. 2024 revenue was $1.04B. 2024 operating profit was −$84M.

Reported results

Emergent BioSolutions notifications

Quantus Signal · live data · not investment advice · Privacy Policy